| Dr Neil D Wallen, MD | |
|
933 Highway 126, Bristol, TN 37620-3310 | |
| (423) 844-7000 | |
| (423) 844-7007 |
| Full Name | Dr Neil D Wallen |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 39 Years |
| Location | 933 Highway 126, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326043373 | NPI | - | NPPES |
| 1326043373 | Medicaid | VA | |
| 006002188 | Medicaid | VA | |
| 1510634 | Medicaid | TN | |
| 3032572 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | MD0000017754 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Holston Medical Group Pc | 8224935754 | 221 |
News Archive
When the revolutionary Echo® acoustic liquid handler is used in the process of discovering potential therapeutics, important drug candidates are identified that are missed using traditional liquid handlers. In a recently issued patent, the global pharmaceutical company AstraZeneca describes the discovery of a novel set of potential cancer therapeutics that was found only when the Echo system was used. Other major pharmaceutical companies have also reported that the Echo liquid handler was a critical platform in discovering drug candidates.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
A group of experts, led by researchers at the Johns Hopkins Bloomberg School of Public Health in collaboration with the Clinton Foundation, today issued a new report with comprehensive recommendations aimed at stemming the opioid epidemic, a spiraling crisis that kills on average 90 people a day in the U.S., and shows few signs of reversing.
A pivotal report issued today by the Institute of Medicine (IOM) rejects childhood vaccines as a cause of autism. The findings, based on reviews of current scientific evidence, are a significant affirmation of vaccine safety, according to the American Academy of Pediatrics (AAP).
› Verified 5 days ago
| Entity Name | Holston Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831110667 PECOS PAC ID: 8224935754 Enrollment ID: O20031216000416 |
News Archive
When the revolutionary Echo® acoustic liquid handler is used in the process of discovering potential therapeutics, important drug candidates are identified that are missed using traditional liquid handlers. In a recently issued patent, the global pharmaceutical company AstraZeneca describes the discovery of a novel set of potential cancer therapeutics that was found only when the Echo system was used. Other major pharmaceutical companies have also reported that the Echo liquid handler was a critical platform in discovering drug candidates.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
A group of experts, led by researchers at the Johns Hopkins Bloomberg School of Public Health in collaboration with the Clinton Foundation, today issued a new report with comprehensive recommendations aimed at stemming the opioid epidemic, a spiraling crisis that kills on average 90 people a day in the U.S., and shows few signs of reversing.
A pivotal report issued today by the Institute of Medicine (IOM) rejects childhood vaccines as a cause of autism. The findings, based on reviews of current scientific evidence, are a significant affirmation of vaccine safety, according to the American Academy of Pediatrics (AAP).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neil D Wallen, MD Po Box 9, Kingsport, TN 37662-0009 Ph: (423) 844-7000 | Dr Neil D Wallen, MD 933 Highway 126, Bristol, TN 37620-3310 Ph: (423) 844-7000 |
News Archive
When the revolutionary Echo® acoustic liquid handler is used in the process of discovering potential therapeutics, important drug candidates are identified that are missed using traditional liquid handlers. In a recently issued patent, the global pharmaceutical company AstraZeneca describes the discovery of a novel set of potential cancer therapeutics that was found only when the Echo system was used. Other major pharmaceutical companies have also reported that the Echo liquid handler was a critical platform in discovering drug candidates.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
A group of experts, led by researchers at the Johns Hopkins Bloomberg School of Public Health in collaboration with the Clinton Foundation, today issued a new report with comprehensive recommendations aimed at stemming the opioid epidemic, a spiraling crisis that kills on average 90 people a day in the U.S., and shows few signs of reversing.
A pivotal report issued today by the Institute of Medicine (IOM) rejects childhood vaccines as a cause of autism. The findings, based on reviews of current scientific evidence, are a significant affirmation of vaccine safety, according to the American Academy of Pediatrics (AAP).
› Verified 5 days ago